Dopamine Hypothesis

The Dopamine Hypothesis of Schizophrenia

The dopamine hypothesis is the most influential neurochemical theory of schizophrenia. It has evolved from a simple proposal in the 1960s — that excess dopamine activity causes psychosis — to a more nuanced, pathway-specific account that attempts to explain both positive and negative symptoms through different dopaminergic dysregulations in different brain circuits.

The Original Dopamine Hypothesis

The original hypothesis emerged from two converging observations in the 1960s. First, antipsychotic drugs (chlorpromazine, haloperidol) — which were known to block dopamine D2 receptors — were effective at reducing positive symptoms. Second, drugs that increase dopamine activity (amphetamine, cocaine) can induce psychotic states in healthy individuals and worsen existing psychosis. These observations suggested that positive symptoms arise from excessive dopamine D2 receptor stimulation — particularly in the mesolimbic pathway (from the ventral tegmental area to the nucleus accumbens and limbic system).

The Revised Dopamine Hypothesis

The original hypothesis could not explain negative symptoms or cognitive deficits — and antipsychotics that reduce D2 activity do not improve (and may worsen) these. Davis et al. (1991) and subsequent researchers proposed a revised account with two components:

Mesolimbic hyperactivity → Positive symptoms: excess dopamine transmission in the mesolimbic pathway (VTA → nucleus accumbens → limbic structures) produces hallucinations, delusions, and aberrant salience — the tendency to assign excessive significance to irrelevant stimuli. Antipsychotic D2 blockade in this pathway reduces positive symptoms.

Mesocortical hypoactivity → Negative symptoms and cognitive deficits: insufficient dopamine transmission in the mesocortical pathway (VTA → prefrontal cortex, particularly DLPFC) produces the negative and cognitive symptom clusters — avolition, alogia, affective flattening, and impaired working memory. D2 blockade in this pathway would worsen these symptoms, explaining the treatment resistance of negative symptoms to antipsychotics.

Aberrant Salience

Kapur (2003) proposed that the mesolimbic dopamine system normally signals the importance or salience of stimuli, directing attention and motivation towards what is biologically or personally significant. In schizophrenia, aberrant (excessive and context-inappropriate) dopamine signalling causes irrelevant stimuli to acquire excessive salience — random events seem meaningful, neutral strangers' conversations seem significant, and internal neural noise becomes experienced as external voices. The delusion is understood as the patient's attempt to make sense of these overwhelming experiences of meaning — they construct an explanatory narrative around stimuli that their dopamine system has tagged as important.

Evaluation

The dopamine hypothesis has strong pharmacological support: the clinical potency of antipsychotics correlates with their D2 binding affinity (Seeman et al., 1976). PET scanning has directly demonstrated elevated dopamine synthesis capacity and D2 receptor availability in schizophrenic patients (Abi-Dargham et al., 2000). However, the hypothesis is incomplete: not all patients respond to antipsychotics; some effective antipsychotics (clozapine) have relatively weak D2 affinity; and serotonin, glutamate (NMDA hypofunction hypothesis), and GABA systems also play important roles. The dopamine hypothesis likely describes a final common pathway rather than the primary cause.